ProBioGen AG announced today that Serono S.A., Switzerland has signed an Agreement to evaluate ProBioGen’s novel human neuronal cell line for the production of recombinant proteins.
ProBioGen AG announced today that Serono S.A., Switzerland has signed an Agreement to evaluate ProBioGen’s novel human neuronal cell line for the production of recombinant proteins.